StockData
Candel Therapeutics, Inc. logo

Candel Therapeutics, Inc. (CADL) stock

CADLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$5.32−0.08 (-1.48%)

Close on Nov 18, 2026Market cap $407.08MP/E –Yield –

Candel Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Candel Therapeutics's price to sales ratio was 298.4× on Apr 28, 2023.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 2023298.4×−118.6
2022Dec 30, 2022417.1×–

More Candel Therapeutics figures

See a number that looks wrong?